Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Queensland Health
Teva
Deloitte
US Army
Accenture
Express Scripts
Federal Trade Commission

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065072

« Back to Dashboard

NDA 065072 describes CEFOTAXIME, which is a drug marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, and Lupin, and is included in fourteen NDAs. It is available from three suppliers. Additional details are available on the CEFOTAXIME profile page.

The generic ingredient in CEFOTAXIME is cefotaxime sodium. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 065072
Tradename:CEFOTAXIME
Applicant:Hikma
Ingredient:cefotaxime sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 065072
Ingredient-typeCephalosporins
Medical Subject Heading (MeSH) Categories for 065072
Suppliers and Packaging for NDA: 065072
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 065072 ANDA West-Ward Pharmaceutical Corp 0143-9930 N 0143-9930-10
CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 065072 ANDA West-Ward Pharmaceutical Corp 0143-9931 N 0143-9931-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Nov 20, 2002TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Nov 20, 2002TE:APRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Nov 20, 2002TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Chubb
McKinsey
QuintilesIMS
UBS
US Army
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.